Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

The role of adiponectin in cholesterol efflux and HDL biogenesis and metabolism.

Hafiane A, Gasbarrino K, Daskalopoulou SS.

Metabolism. 2019 Aug 1;100:153953. doi: 10.1016/j.metabol.2019.153953. [Epub ahead of print] Review.

PMID:
31377319
2.

Vulnerable Plaque, Characteristics, Detection, and Potential Therapies.

Hafiane A.

J Cardiovasc Dev Dis. 2019 Jul 27;6(3). pii: E26. doi: 10.3390/jcdd6030026. Review.

3.

ABCA1 Agonist Mimetic Peptide CS-6253 Induces Microparticles Release From Different Cell Types by ABCA1-Efflux-Dependent Mechanism.

Hafiane A, Johansson JO, Genest J.

Can J Cardiol. 2019 Jun;35(6):770-781. doi: 10.1016/j.cjca.2019.02.018. Epub 2019 Feb 27.

PMID:
31151713
4.

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification.

Yu B, Hafiane A, Thanassoulis G, Ott L, Filwood N, Cerruti M, Gourgas O, Shum-Tim D, Al Kindi H, de Varennes B, Alsheikh-Ali A, Genest J, Schwertani A.

JACC Basic Transl Sci. 2017 Aug 28;2(4):358-371. doi: 10.1016/j.jacbts.2017.03.015. eCollection 2017 Aug.

5.

Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease.

Hafiane A, Daskalopoulou SS.

Metabolism. 2018 Aug;85:213-222. doi: 10.1016/j.metabol.2018.04.008. Epub 2018 May 1. Review.

PMID:
29727628
6.

Decreased Adiponectin-Mediated Signaling Through the AdipoR2 Pathway Is Associated With Carotid Plaque Instability.

Gasbarrino K, Zheng H, Hafiane A, Veinot JP, Lai C, Daskalopoulou SS.

Stroke. 2017 Apr;48(4):915-924. doi: 10.1161/STROKEAHA.116.015145. Epub 2017 Mar 3.

PMID:
28258256
7.

ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis.

Hafiane A, Genest J.

Atherosclerosis. 2017 Feb;257:90-99. doi: 10.1016/j.atherosclerosis.2017.01.013. Epub 2017 Jan 17.

PMID:
28129550
8.

High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management.

Choi HY, Hafiane A, Schwertani A, Genest J.

Can J Cardiol. 2017 Mar;33(3):325-333. doi: 10.1016/j.cjca.2016.09.012. Epub 2016 Oct 20. Review.

PMID:
28063740
9.

High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.

Hafiane A, Genest J.

BBA Clin. 2015 Jan 31;3:175-88. doi: 10.1016/j.bbacli.2015.01.005. eCollection 2015 Jun. Review.

10.

HDL-Mediated Cellular Cholesterol Efflux Assay Method.

Hafiane A, Genest J.

Ann Clin Lab Sci. 2015 Fall;45(6):659-68.

PMID:
26663796
11.

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Hafiane A, Bielicki JK, Johansson JO, Genest J.

PLoS One. 2015 Jul 24;10(7):e0131997. doi: 10.1371/journal.pone.0131997. eCollection 2015.

12.

Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro.

Hafiane A, Bielicki JK, Johansson JO, Genest J.

Biochim Biophys Acta. 2014 Oct;1842(10):1498-512. doi: 10.1016/j.bbalip.2014.07.018. Epub 2014 Aug 1.

PMID:
25091998
13.

Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.

Al Kindi H, Hafiane A, You Z, Albanese I, Pilote L, Genest J, Schwertani A.

Peptides. 2014 May;55:151-7. doi: 10.1016/j.peptides.2014.03.004. Epub 2014 Mar 16.

PMID:
24642358
14.

Treatment options for low high-density lipoproteins.

Hafiane A, Kellett S, Genest J.

Curr Opin Endocrinol Diabetes Obes. 2014 Apr;21(2):134-9. doi: 10.1097/MED.0000000000000049. Review.

PMID:
24535232
15.

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.

Jabor B, Choi H, Ruel I, Hafiane A, Mourad W, Genest J.

Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2.

PMID:
24267807
16.

High-density lipoprotein mediated cellular cholesterol efflux in acute coronary syndromes.

Hafiane A, Jabor B, Ruel I, Ling J, Genest J.

Am J Cardiol. 2014 Jan 15;113(2):249-55. doi: 10.1016/j.amjcard.2013.09.006. Epub 2013 Oct 2.

PMID:
24210679
17.

HDL, Atherosclerosis, and Emerging Therapies.

Hafiane A, Genest J.

Cholesterol. 2013;2013:891403. doi: 10.1155/2013/891403. Epub 2013 May 28.

18.

Genetic and pharmacological manipulation of urotensin II ameliorate the metabolic and atherosclerosis sequalae in mice.

You Z, Genest J Jr, Barrette PO, Hafiane A, Behm DJ, D'Orleans-Juste P, Schwertani AG.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1809-16. doi: 10.1161/ATVBAHA.112.252973. Epub 2012 Jun 21.

PMID:
22723440
19.

Tweaking the cholesterol efflux capacity of reconstituted HDL.

Ma CI, Beckstead JA, Thompson A, Hafiane A, Wang RH, Ryan RO, Kiss RS.

Biochem Cell Biol. 2012 Oct;90(5):636-45. doi: 10.1139/o2012-015. Epub 2012 May 18.

20.

Engulfment protein GULP is regulator of transforming growth factor-β response in ovarian cells.

Ma CI, Martin C, Ma Z, Hafiane A, Dai M, Lebrun JJ, Kiss RS.

J Biol Chem. 2012 Jun 8;287(24):20636-51. doi: 10.1074/jbc.M111.314997. Epub 2012 Mar 26.

Supplemental Content

Loading ...
Support Center